Virtu Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Virtu Financial’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-47,458	Closed	-$5.4M	–	2505
2022 Q4	$5.4M	Buy	+47,458	New	+$3.94M	0.71%	9
2022 Q3	–	Sell	-19,913	Closed	-$1.59M	–	2560
2022 Q2	$1.59M	Buy	+19,913	New	+$1.89M	0.13%	128
2021 Q4	–	Sell	-4,514	Closed	-$494K	–	2472
2021 Q3	$494K	Buy	+4,514	New	+$469K	0.04%	469
2020 Q4	–	Sell	-17,210	Closed	-$1.34M	–	1997
2020 Q3	$1.34M	Buy	17,210 +8,992	+109%	+$619K	0.23%	90
2020 Q2	$457K	Buy	+8,218	New	+$352K	0.05%	402
2019 Q3	–	Sell	-10,591	Closed	-$255K	–	2067
2019 Q2	$255K	Buy	+10,591	New	+$269K	0.01%	881

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial's HZNP Position: Q1 2023 in Review

Virtu Financial sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 47,458 shares — an estimated $5.4M sold.

Virtu Financial first reported a position in HZNP in Q2 2019 and held it in 6 quarters. The position peaked at $5.4M in Q4 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Virtu Financial reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Virtu Financial sold 47,458 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $5.4M.
Virtu Financial first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 6 quarters.
Virtu Financial's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.4M in Q4 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.